TOVX Return on Tangible Equity | Theriva Biologics, Inc.

Theriva Biologics, Inc. (TOVX) Return on Tangible Equity

2026-06-30: Return Tang Equity 152.61%.
2026-03-31: Return Tang Equity 487.59%.
2025-12-31: Return Tang Equity 537.45%.
2025-09-30: Return Tang Equity 200.51%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	152.61%
2026-03-31	487.59%
2025-12-31	537.45%
2025-09-30	200.51%
2025-06-30	322.06%
2025-03-31	576.64%
2024-12-31	3499.86%
2024-09-30	-792.05%
2024-06-30	-480.45%
2024-03-31	-316.44%
2023-12-31	-160.08%
2023-09-30	-54.10%
2023-06-30	-52.03%
2023-03-31	-48.26%
2022-12-31	-43.57%
2022-09-30	-37.12%
2022-06-30	-31.74%
2022-03-31	-25.72%
2021-12-31	-21.81%
2021-09-30	-15.19%
2021-06-30	-13.03%
2021-03-31	-12.11%
2020-12-31	203.08%
2020-09-30	177.77%
2020-06-30	340.01%
2020-03-31	1134.80%
2019-12-31	-931.54%
2019-09-30	-322.74%
2019-06-30	-141.17%
2019-03-31	-109.13%
2018-12-31	-79.14%
2018-09-30	187.77%
2018-06-30	218.84%
2018-03-31	435.26%
2017-12-31	906.27%
2017-09-30	410.73%
2017-06-30	-383.27%
2017-03-31	-805.43%
2016-12-31	-743.30%
2016-09-30	770.53%
2016-06-30	-1620.35%
2016-03-31	-694.50%
2015-12-31	-275.55%
2015-09-30	-152.73%
2015-06-30	270.04%
2015-03-31	1569.63%
2014-12-31	-210.97%
2014-09-30	-489.78%
2014-06-30	-202.90%
2014-03-31	-120.27%
2013-12-31	-81.83%
2013-09-30	-325.63%
2013-06-30	-203.05%
2013-03-31	-160.00%
2012-12-31	-132.83%
2012-09-30	-156.52%
2012-03-31	-92.69%
2011-12-31	-118.43%
2011-09-30	-70.63%
2011-06-30	-61.16%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	537.45%
2024-12-31	3499.73%
2023-12-31	-58.69%
2022-12-31	-42.51%
2021-12-31	-21.81%
2020-12-31	210.68%
2019-12-31	-840.36%
2018-12-31	-78.32%
2017-12-31	1014.30%
2016-12-31	-708.84%
2015-12-31	-272.49%
2014-12-31	-207.03%
2013-12-31	-80.87%
2012-12-31	-131.01%
2011-12-31	-115.44%
2010-12-31	-47.81%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
KALA BIO, Inc. (KALA)	United States	$0.011B	-3.33
MetaVia Inc. (MTVA)	United States	$0.011B	-0.65
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
Azitra, Inc. (AZTR)	United States	$0.010B	-0.81
Medicus Pharma Ltd. (MDCX)		$0.010B
Dare Bioscience, Inc. (DARE)	United States	$0.011B
Aprea Therapeutics, Inc. (APRE)	United States	$0.010B	-0.78
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B
Scienture Holdings, Inc. (SCNX)	United States	$0.012B	-0.38
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92